In the last year, in the scramble to treat America's growing obesity problem (without, you know, telling Americans what to do or cutting ties with unhealthy lobbies), the FDA did something it hadn't done in 13 years: Approved two new weight loss supplements, Belviq and Qsymia. Today, Qsymia*is...
VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced that the first patient has received the FDA-approved Implantable Miniature Telescope (by Dr. Isaac Lipshitz) procedure indicated to improve vision in patients with end-stage age-related...
A computer-based diabetes simulation tool developed by University of Virginia researchers is now commercially available, thanks to a partnership with the Charlottesville-based medical research firm The Epsilon Group. The simulator is the only protocol that has been accepted by the U.S. Food and...
A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. Methodist will be the first hospital in...